IRROG Galway is part of the national Irish Research Radiation Oncology Group (IRROG), and sits within HRB-CRFG for research governance.

IRROG is a national platform for delivering high-quality national and international trials to patients receiving radiotherapy, and was founded with HRB grant CTIC-2021-007 of €2.37 million with matching co-funds. Prof. Joseph Martin is a founding member and co-applicant of IRROG, and leads the Galway unit.

The team comprises full-time research assistants and FTEs in Radiation Therapy, Physics and Dosimetry.

Since commencement, IRROG Galway has successfully opened and recruited to a number of international phase 3 interventional trials, and is currently developing a number of in-house IIT’s. These include CompARE, DASL HiCAP, NRG HN009, EXPERT, SIMPLIFY and PRESERVE.

IRROG Galway is committed to collaboration, and welcomes enquiries from the clinical and university communities. Please contact emma.stone@universityofgalway.ie or joseph.martin@universityofgalway.ie